TRPM8 and prostate carcinoma: Furthermore, androgens were known to regulate transient receptor potential melastatin 8 (TRPM8) protein expression through AR activation in prostate cancer development, and TRPM8 activity was reported to suppress prostate cancer cell migration (Grolez et al. 2019).